Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy
James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, et al.
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 6, pp. 435-449
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Mechanisms of action of fluvoxamine for COVID-19: a historical review
Yaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
Molecular Psychiatry (2022) Vol. 27, Iss. 4, pp. 1898-1907
Open Access | Times Cited: 109
COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review
Marc D. Binder, Victor Mazereel, Marc Stroobants, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 57
Long COVID, neuropsychiatric disorders, psychotropics, present and future
Siu Wa Tang, Brian E. Leonard, Daiga M. Helmeste
Acta Neuropsychiatrica (2022) Vol. 34, Iss. 3, pp. 109-126
Open Access | Times Cited: 47
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders
Dicson Sheeja Malar, Premrutai Thitilertdecha, Kanokphorn S Ruckvongacheep, et al.
CNS Drugs (2023) Vol. 37, Iss. 5, pp. 399-440
Open Access | Times Cited: 32
Therapeutic Strategies Targeting Mitochondrial Calcium Signaling: A New Hope for Neurological Diseases?
Laura R. Rodríguez, Tamara Lapeña-Luzón, Noelia Benetó, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 165-165
Open Access | Times Cited: 29
Overview of the potential use of fluvoxamine for COVID-19 and long COVID
Kenji Hashimoto
Discover Mental Health (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 20
Fluvoxamine Exerts Sigma-1R to Rescue Autophagy via Pom121-Mediated Nucleocytoplasmic Transport of TFEB
Chun‐Yu Lin, Hsiang-En Wu, Eddie Feng-Ju Weng, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 8, pp. 5282-5294
Open Access | Times Cited: 6
Plant Polyphenols for Aging Health: Implication from Their Autophagy Modulating Properties in Age-Associated Diseases
James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 982-982
Open Access | Times Cited: 34
Antidepressants for COVID-19: A systematic review
Wei Zheng, Heli Sun, Hong Cai, et al.
Journal of Affective Disorders (2022) Vol. 307, pp. 108-114
Open Access | Times Cited: 23
Targeting Selective Autophagy as a Therapeutic Strategy for Viral Infectious Diseases
Yishan Liu, Tao Zhou, Jiajia Hu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 19
Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes
Dicson Sheeja Malar, Kanika Verma, Mani Iyer Prasanth, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Autophagy and Respiratory Viruses: Mechanisms, Viral Exploitation, and Therapeutic Insights
Farnaz Aligolighasemabadi, Estera Bakinowska, Kajetan Kiełbowski, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 418-418
Open Access
Mechanistic insights into the role of plant polyphenols and their nano-formulations in the management of depression
Atul Kabra, Ruchika Garg, James Michael Brimson, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Simple ammonium salt and sigma-1 receptor ligand dipentylammonium provides neuroprotective effects in cell culture and Caenorhabditis elegans models of Alzheimer's disease
Mani Iyer Prasanth, Kanika Verma, Sirikalaya Brimson, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116455-116455
Open Access | Times Cited: 2
Mitochondria in COVID-19: from cellular and molecular perspective
Michał Rurek
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 2
Sigma-1 Receptor in Retina: Neuroprotective Effects and Potential Mechanisms
Zifen Xu, Yushuang Lei, Huan Qin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7572-7572
Open Access | Times Cited: 11
Fluvoxamine for the treatment of COVID-19
Michael Dodds, Eileen Doyle, Angela M. Reiersen, et al.
The Lancet Global Health (2022) Vol. 10, Iss. 3, pp. e332-e332
Open Access | Times Cited: 10
Synthesis and characterization of the two enantiomers of a chiral sigma-1 receptor radioligand: (S)-(+)- and (R)-(-)-[18F]FBFP
Tao Wang, Ying Zhang, Xiaojun Zhang, et al.
Chinese Chemical Letters (2022) Vol. 33, Iss. 7, pp. 3543-3548
Closed Access | Times Cited: 8
Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.
H-F Wei, Samuel Anchipolovsky, Renzo E. Vera, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 26, Iss. 6, pp. 2201-2214
Closed Access | Times Cited: 7
Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study
Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 12, pp. 1087-1097
Closed Access | Times Cited: 6
Donepezil-associated survival benefits among Alzheimer’s disease patients are retained but not enhanced during COVID-19 infections
Elizabeth Edmiston, Taissa Bej, Brigid Wilson, et al.
Therapeutic Advances in Infectious Disease (2023) Vol. 10, pp. 204993612311742-204993612311742
Open Access | Times Cited: 3
A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach
Francesca Serena Abatematteo, Pietro Delre, Ivan Mercurio, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Molecular Bases of Serotonin Reuptake Inhibitor Antidepressant-Attributed Effects in COVID-19: A New Insight on the Role of Bradykinins
Ahmed S. Gouda, Bruno Mégarbane
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1487-1487
Open Access | Times Cited: 5
Bacopa monnieri protects neuronal cell line and Caenorhabditis elegans models of Alzheimer’s disease through sigma-1 receptor antagonist sensitive and antioxidant pathways
James Michael Brimson, Mani Iyer Prasanth, Discon Sheeja Malar, et al.
Nutrition and Healthy Aging (2022) Vol. 7, Iss. 3-4, pp. 173-196
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top